Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Immucor has signed a definitive agreement to acquire BioArray Solutions, a privately held company that has pioneered the development of molecular diagnostic systems.
Subscribe to our email newsletter
The purchase price will be approximately $117 million in cash. The current equity holders of BioArray intend to form a new company prior to closing, to commercialize BioArray technologies in fields outside of blood transfusion and transplantation. In connection with its acquisition of BioArray, Immucor will receive a 19% ownership interest in this new company.
Gioacchino De Chirico, president and CEO of Immucor, said: “This is a landmark acquisition for Immucor which will enable us to provide innovative molecular diagnostic solutions for blood transfusions that complement our current product line. This acquisition also opens up broader opportunities for Immucor in transplantation and transfusion-related applications.”